MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-11-0008497
Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals Private Limited - trading in Uttamnagar, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹39.76 Lakh
▼ 7% YoY
Net loss · FY 2025
₹3.8 Lakh
Net margin -9.6%
EBITDA · FY 2025
-₹3.24 Lakh
EBITDA margin -8.2%
Authorised capital
₹6 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered
About Axonwave Pharmaceuticals Private Limited
Data last updated:
Axonwave Pharmaceuticals Private Limited is a private limited company based in Uttamnagar, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 24 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2020PTC372134. Its GSTIN is 07AAUCA2734Q1ZY (Delhi).
The company has an authorised share capital of ₹6 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Ananya Bhasin and Kanchan Banga.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 178 Kh No.117 Vipin Garden Extn., Uttamnagar, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.76 Lakh, a decline of 7% compared to the previous year. For the same year it recorded a net loss of ₹3.8 Lakh (net margin -9.6%) and EBITDA of -₹3.24 Lakh (EBITDA margin -8.2%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years.
Axonwave Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0008497).
Company Details of Axonwave Pharmaceuticals Private Limited
CIN U51909DL2020PTC372134
Registration Number 372134
Incorporation Date 24 October 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0008497
Recognitions & Rankings of Axonwave Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 178 Kh No.117 Vipin Garden Extn., Uttamnagar, Delhi, India – 110059
- IndustryTrading, Specialty, Wholesale
Comprehensive company report
Axonwave Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Axonwave Pharmaceuticals Private Limited
The main business activity of Axonwave Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Axonwave Pharmaceuticals Private Limited FY 2025 filings available
Axonwave Pharmaceuticals Private Limited reported revenue of ₹39.76 Lakh (down 7% YoY) for FY 2025.
Revenue · FY 2025
₹39.76 Lakh ▼ 7%
Net loss · FY 2025
₹3.8 Lakh margin -9.6%
EBITDA · FY 2025
-₹3.24 Lakh margin -8.2%
Compounded Annual Growth Rate (CAGR) of Axonwave Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▼ 7%
3 years · compounded
▼ 14%
EBITDA CAGR growth
1 year
▼ 505%
3 years · compounded
▼ 83%
Revenue has declined at a compounded annual rate (CAGR) of 14% over three years, including a 7% fall in the latest year. EBITDA fell 505% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Axonwave Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.24 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.8 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Axonwave Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -9.6% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Axonwave Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals has 5 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ananya Bhasin Also directs: Aass Pharma Private Limited | Director | 02 Apr 2021 | 5 Years 6 Months | Current |
| Kanchan Banga | Director | 02 Apr 2021 | 5 Years 6 Months | Current |
| Prashant Kumar | Director | 24 Oct 2020 | 5 Years 11 Months | Current |
| Neha Chanana | Director | 24 Oct 2020 | 5 Years 11 Months | Current |
| Pramila Gupta Also directs: Delhi Epilepsy and Stroke Foundation | Director | 24 Oct 2020 | 5 Years 11 Months | Current |
Peer Comparison of Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Steenbrass Pharmaceuticals Private Limited | ₹40.17 Lakh (FY 2015) | •••• | •••• | -12.0% | •••• | Mumbai, Maharashtra, India |
| Blazed Pharmaceuticals Private Limited | ₹40.08 Lakh (FY 2025) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Blissderma Pharmaceuticals Private Limited | ₹40.02 Lakh (FY 2025) | •••• | •••• | 39.0% | •••• | Pune, Maharashtra, India |
| Vitabolik Pharmaceuticals Private Limited | ₹39.95 Lakh (FY 2025) | •••• | •••• | -64.0% | •••• | Mumbai, Maharashtra, India |
| Welltass Pharmaceuticals Private Limited | ₹39.92 Lakh (FY 2025) | •••• | •••• | -6.0% | •••• | Greater Noida, Uttar Pradesh, India |
| Axonwave Pharmaceuticals Private Limited this company | ₹39.76 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Uttamnagar, Delhi, India |
| Coris Chemicals and Pharmaceuticals Private Limited | ₹39.7 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Surat, Gujarat, India |
| Nihit Pharmaceuticals Private Limited | ₹39.68 Lakh (FY 2021) | •••• | •••• | 560.0% | •••• | Pune, Maharashtra, India |
| Delmax Pharmaceuticals Private Limited | ₹39.68 Lakh (FY 2024) | •••• | •••• | -5.0% | •••• | Aurangabad, Maharashtra, India |
| Earl Pharmaceuticals Private Limited | ₹39.67 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Bareily, Uttar Pradesh, India |
| Pharmella Pharmaceuticals Private Limited | ₹39.64 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Eluru, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Axonwave Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Ownership and Shareholding of Axonwave Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals Private Limited has a workforce of 0 employees as of Apr 08, 2024.
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals Private Limited has 5 board changes on record since 2020: 5 appointments. The latest: Ananya Bhasin was appointed as Director on 02 Apr 2021.
AGM
Axonwave Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Axonwave Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Appointed
Ananya Bhasin was appointed as Director.
Appointed
Kanchan Banga was appointed as Director.
Appointed
Neha Chanana was appointed as Director.
Appointed
Pramila Gupta was appointed as Director.
Appointed
Prashant Kumar was appointed as Director.
Incorporation
24 Oct 2020
Axonwave Pharmaceuticals Private Limited was registered on 24 Oct 2020 with Roc Delhi Ii & aged 5 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Axonwave Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Axonwave Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Axonwave Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAUCA2734Q1ZY | Delhi | Active | 10 Nov 2020 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Axonwave Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Axonwave Pharmaceuticals Private Limited
Axonwave Pharmaceuticals is an active private limited company based in Uttamnagar, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 24 October 2020 (6+ years old) and is registered under CIN U51909DL2020PTC372134.
Axonwave Pharmaceuticals reported revenue of ₹39.76 Lakh for FY 2025 (down 7% YoY).
Axonwave Pharmaceuticals has 5 current directors:
- Ananya Bhasin - Director
- Kanchan Banga - Director
- Prashant Kumar - Director
- Neha Chanana - Director
- Pramila Gupta - Director
Axonwave Pharmaceuticals reported a net loss of ₹3.8 Lakh (net margin -9.6%) and EBITDA of -₹3.24 Lakh (EBITDA margin -8.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Axonwave Pharmaceuticals is -14% over three years. In the latest year (FY 2025) revenue fell 7%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Axonwave Pharmaceuticals is 07AAUCA2734Q1ZY, registered in Delhi.
The CIN (Corporate Identification Number) of Axonwave Pharmaceuticals is U51909DL2020PTC372134. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axonwave Pharmaceuticals was incorporated on 24 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Axonwave Pharmaceuticals by revenue are Steenbrass Pharmaceuticals Private Limited, Blazed Pharmaceuticals Private Limited, Blissderma Pharmaceuticals Private Limited, Vitabolik Pharmaceuticals Private Limited, Welltass Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ananya Bhasin was appointed as Director on 02 Apr 2021. Kanchan Banga was appointed as Director on 02 Apr 2021. Neha Chanana was appointed as Director on 24 Oct 2020. Axonwave Pharmaceuticals has 5 board changes on record in total.
Yes, Axonwave Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0008497).